Our ALDH1A3 knockout results in A172 glioblastoma cells align with other studies showing that reduced ALDH activity increases sensitivity to chemotherapeutic agents like TMZ, possibly due to enhanced lipid peroxidation and impaired autophagy. This evidence concerns the gene ALDH1A3 and glioblastoma.